EE200000340A - Uudsed uretaanid, nende tio- ja ditioanaloogid, nende soolad, neid ühendeid sisaldavad ravimid ja nende kasutamine, samuti meetod nende valmistamiseks - Google Patents

Uudsed uretaanid, nende tio- ja ditioanaloogid, nende soolad, neid ühendeid sisaldavad ravimid ja nende kasutamine, samuti meetod nende valmistamiseks

Info

Publication number
EE200000340A
EE200000340A EEP200000340A EEP200000340A EE200000340A EE 200000340 A EE200000340 A EE 200000340A EE P200000340 A EEP200000340 A EE P200000340A EE P200000340 A EEP200000340 A EE P200000340A EE 200000340 A EE200000340 A EE 200000340A
Authority
EE
Estonia
Prior art keywords
thio
salts
preparation
well
medicaments containing
Prior art date
Application number
EEP200000340A
Other languages
English (en)
Estonian (et)
Inventor
Maier Roland
M�ller Peter
Adelgoss Gebhard
Schilcher Gebhard
Hurnaus Rudolf
Mark Michael
Eisele Bernhard
Original Assignee
Boehringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Kg filed Critical Boehringer Ingelheim Pharma Kg
Publication of EE200000340A publication Critical patent/EE200000340A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/04Drugs for disorders of the urinary system for urolithiasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/24Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/40Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/56Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/02Monothiocarbamic acids; Derivatives thereof
    • C07C333/06Monothiocarbamic acids; Derivatives thereof having nitrogen atoms of thiocarbamic groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/14Dithiocarbamic acids; Derivatives thereof
    • C07C333/18Esters of dithiocarbamic acids
    • C07C333/24Esters of dithiocarbamic acids having nitrogen atoms of dithiocarbamate groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
EEP200000340A 1997-12-10 1998-12-08 Uudsed uretaanid, nende tio- ja ditioanaloogid, nende soolad, neid ühendeid sisaldavad ravimid ja nende kasutamine, samuti meetod nende valmistamiseks EE200000340A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19754795A DE19754795A1 (de) 1997-12-10 1997-12-10 Neue Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
PCT/EP1998/007962 WO1999029662A2 (de) 1997-12-10 1998-12-08 Urethane, ihre thio- und dithioanaloga, deren salze, diese verbindungen enthaltende arzneimittel und deren verwendung sowie verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
EE200000340A true EE200000340A (et) 2001-08-15

Family

ID=7851380

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000340A EE200000340A (et) 1997-12-10 1998-12-08 Uudsed uretaanid, nende tio- ja ditioanaloogid, nende soolad, neid ühendeid sisaldavad ravimid ja nende kasutamine, samuti meetod nende valmistamiseks

Country Status (30)

Country Link
US (1) US6346545B1 (ru)
EP (1) EP1045832B1 (ru)
JP (1) JP4001317B2 (ru)
KR (1) KR20010024708A (ru)
CN (1) CN1281431A (ru)
AR (1) AR014405A1 (ru)
AT (1) ATE291570T1 (ru)
AU (1) AU747173B2 (ru)
BG (1) BG104501A (ru)
BR (1) BR9813545A (ru)
CA (1) CA2310055C (ru)
CO (1) CO5290251A1 (ru)
CZ (1) CZ20002150A3 (ru)
DE (2) DE19754795A1 (ru)
EA (1) EA003298B1 (ru)
EE (1) EE200000340A (ru)
HR (1) HRP980621A2 (ru)
HU (1) HUP0100292A3 (ru)
ID (1) ID21432A (ru)
IL (1) IL135737A0 (ru)
NO (1) NO20002968L (ru)
NZ (1) NZ505594A (ru)
PE (1) PE133599A1 (ru)
PL (1) PL341654A1 (ru)
SK (1) SK8602000A3 (ru)
TR (1) TR200001636T2 (ru)
UY (1) UY25288A1 (ru)
WO (1) WO1999029662A2 (ru)
YU (1) YU35500A (ru)
ZA (1) ZA9811263B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR071458A1 (es) * 2008-02-22 2010-06-23 Basf Se Composiciones fungicidas con 3'-bromo-2,3,4,6'-tetrametoxi-2',6-dimetilbenzofenona
CA2822207A1 (en) * 2010-12-27 2012-07-05 The Curators Of The University Of Missouri Oxidosqualene cyclase as a protein target for anticancer therapeutics

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2025490C (en) * 1989-09-22 2003-09-16 James R. Mccarthy Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis
US5011859A (en) * 1990-03-30 1991-04-30 Merrell Dow Pharmaceuticals Inc. Di- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase
NZ239022A (en) * 1990-07-25 1993-11-25 Merrell Dow Pharma Piperidyl ethers and thioethers; preparatory processes and pharmaceutical compositions
US5084461A (en) * 1991-03-27 1992-01-28 Merrell Dow Pharmaceuticals Inc. Azadecalin amides and thioamides as inhibitors of cholesterol biosynthesis
US5466687A (en) 1992-10-22 1995-11-14 Dr. Karl Thomae Gmbh Arylidene-1-azacycloalkanes and arylalkyl-1-azacyclo-alkanes, their salts, medicaments containing these compounds and their use, and processes for their preparation
DE4303840A1 (de) * 1992-10-22 1994-08-11 Thomae Gmbh Dr K Aryliden-1-azacycloalkane und Arylalkyl-1-azacycloalkane, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
DE4239150A1 (de) 1992-11-20 1994-05-26 Thomae Gmbh Dr K O-Acyl-4-phenyl-cyclohexanole, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
DE4239151A1 (de) 1992-11-20 1994-05-26 Thomae Gmbh Dr K N,N-Disubstituierte Arylcycloalkylamine, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
DE4438020A1 (de) * 1994-10-25 1996-05-02 Thomae Gmbh Dr K N-substituierte Arylcyclohexylacylamine, ihre Salze mit physiologisch verträglichen organischen oder anorganischen Säuren, Verfahren zur Herstellung dieser Verbindungen und diese enthaltende Arzneimittel

Also Published As

Publication number Publication date
YU35500A (sh) 2002-09-19
EA200000633A1 (ru) 2000-12-25
HUP0100292A2 (hu) 2001-07-30
ZA9811263B (en) 2000-06-09
CA2310055A1 (en) 1999-06-17
CZ20002150A3 (cs) 2001-11-14
ATE291570T1 (de) 2005-04-15
US20020019536A1 (en) 2002-02-14
WO1999029662A3 (de) 1999-08-19
EP1045832B1 (de) 2005-03-23
HUP0100292A3 (en) 2002-11-28
TR200001636T2 (tr) 2001-08-21
WO1999029662A2 (de) 1999-06-17
EA003298B1 (ru) 2003-04-24
HRP980621A2 (en) 1999-08-31
CN1281431A (zh) 2001-01-24
ID21432A (id) 1999-06-10
PL341654A1 (en) 2001-04-23
UY25288A1 (es) 2000-12-29
CA2310055C (en) 2008-09-23
KR20010024708A (ko) 2001-03-26
SK8602000A3 (en) 2000-11-07
AU1759399A (en) 1999-06-28
PE133599A1 (es) 2000-01-13
AU747173B2 (en) 2002-05-09
JP4001317B2 (ja) 2007-10-31
IL135737A0 (en) 2001-05-20
NO20002968L (no) 2000-08-09
NZ505594A (en) 2001-11-30
CO5290251A1 (es) 2003-06-27
NO20002968D0 (no) 2000-06-09
EP1045832A2 (de) 2000-10-25
AR014405A1 (es) 2001-02-28
BG104501A (bg) 2001-03-30
JP2001525393A (ja) 2001-12-11
US6346545B1 (en) 2002-02-12
BR9813545A (pt) 2000-10-10
DE59812686D1 (de) 2005-04-28
DE19754795A1 (de) 1999-06-17

Similar Documents

Publication Publication Date Title
NO20002217L (no) Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler
EE9800028A (et) Iprotroopiumsoolad, neid sisaldavad ravimkompositsioonid ja nende kasutamine
NO20011216L (no) Azetidinderivater, deres fremstilling og medikamenter inneholdende forbindelsene
AR241082A1 (es) Nuevos derivados de pirazol utiles como agentes herbicidas, las composiciones herbicidas que los contienen y los procedimientos para producir estos derivados de pirazol".
PT83909B (pt) Processo para a preparacao de 5-amino e 5-hidroxi-6,8-difluoroquinolonas e de composicoes farmaceuticas antibacterianas que as contem
DK0744397T3 (da) Fluorphenylsubstituerede alkenylcarboxylsyre-guanidiner som Na+/K+-antiport-inhibitorer, deres anvendelse som lægemiddel el
NO20001288D0 (no) Substituerte 1,2,3,4,5,6-heksahydro-2,6-metano-3-benzazocin- 10-oler, fremgangsmÕte for fremstilling derav og anvendelse som legemiddel
NO972433D0 (no) Substituerte 2-naftoylguanidiner, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
IT1229563B (it) Composti tipo sali, composizioni farmaceutiche che li contengono e procedimento per la loro preparazione.
EE200000340A (et) Uudsed uretaanid, nende tio- ja ditioanaloogid, nende soolad, neid ühendeid sisaldavad ravimid ja nende kasutamine, samuti meetod nende valmistamiseks
IT9021300A0 (it) Composti aromatici contenenti gruppi solfo, loro preparazione e loro impiego
DK147084A (da) 1-phenyl-3-benzoyl-(thio)-urinstoffer, deres fremstilling og anvendelse som skadedyrsbekaempelsesmidler
HRP980576B1 (en) Sulphonamide substituted benzopyran derivatives, process for their preparation, their use as medicines and pharmaceutical compositions containing them
EE9900174A (et) Konformatsiooniliselt fikseeritud LH-RH analoogid, nende kasutamine ja neid sisaldavad farmatseutilised kompositsioonid
NO973486D0 (no) Substituerte indanylidinacetylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikamenter eller diagnostikum og medikamenter inneholdende forbindelsene
EE200000342A (et) Asatsükloalkaanidest tuletatud uretaanid, nende tio- ja ditioanaloogid, nende valmistamine ja kasutamine 2,3-epoksüskvaleenlanesterooltsüklaasi inhibiitoritena
HUP9801789A3 (en) Sulfonamide substituted compounds, process for producing them, their use for producing pharmaceutical compositions and pharmaceutical compositions containing said compounds
NO873628D0 (no) 2,3-dihydro-1h-fenalen-2-amino-forbindelser som antipsykotiske legemidler.
NO970697L (no) Substituerte tiofenalkenylkarboksylsyreguanidider, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsene
PT87955A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados de dioxopiperidina, com actividade anti-anxiogenica
HRP980066B1 (en) Sulfonamide substituted compounds, processes for their preparation, their use as medicins or diagnostic agents as well as the medicine containing them
DE3562241D1 (de) N,n,-diethyl, n'-aryl, n'-(dichlorfluormethylthio)sulfamide-microbiocides
FI903585A0 (fi) Germisidinen koostumus
PT91259A (pt) Processo para a preparacao de composicoes microbicidas, contendo derivados de halogeno-vinil-azol
DK0534856T3 (da) Thienocyklopentanonoximethere, deres fremstilling samt farmaceutiske sammensætninger indeholdende disse

Legal Events

Date Code Title Description
HC1A Change of owner name